CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates

CareDx (CDNA) delivered earnings and revenue surprises of -250% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Leave a comment

Your email address will not be published. Required fields are marked *